Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF DERMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2017-12-26
DOI
10.1111/bjd.16254
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients
- (2017) Stefano Guadagni et al. MELANOMA RESEARCH
- Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
- (2017) Goran Micevic et al. Clinical Epigenetics
- The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics
- (2017) Chihao Shao et al. PLoS One
- Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel
- (2017) Blanca de Unamuno Bustos et al. Scientific Reports
- Epigenetics in Human Melanoma
- (2017) Paul M. Howell et al. Cancer Control
- Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival
- (2016) Mi Ryung Roh et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- DNA methylation subgroups in melanoma are associated with proliferative and immunological processes
- (2015) Martin Lauss et al. BMC Medical Genomics
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Update on melanoma epigenetics
- (2015) Blanca de Unamuno et al. CURRENT OPINION IN ONCOLOGY
- DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients
- (2015) Érica S. S. de Araújo et al. Biomed Research International
- TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
- (2014) Klaus G. Griewank et al. JNCI-Journal of the National Cancer Institute
- DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations
- (2014) D. M. Marzese et al. NEURO-ONCOLOGY
- DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features
- (2014) Nancy E. Thomas et al. Pigment Cell & Melanoma Research
- DNA Methylation Characteristics of Primary Melanomas with Distinct Biological Behaviour
- (2014) Szilvia Ecsedi et al. PLoS One
- Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis
- (2013) Diego M. Marzese et al. HUMAN MOLECULAR GENETICS
- Prevalence of BRAF and NRAS mutations in fast-growing melanomas
- (2013) Eduardo Nagore et al. Pigment Cell & Melanoma Research
- Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients
- (2012) Luca Sigalotti et al. Journal of Translational Medicine
- Aberrant DNA methylation in malignant melanoma
- (2010) Carolina Schinke et al. MELANOMA RESEARCH
- CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma
- (2009) A. Tanemura et al. CLINICAL CANCER RESEARCH
- Methylation of PTEN as a Prognostic Factor in Malignant Melanoma of the Skin
- (2009) Christoph Lahtz et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CpG island methylation profiling in human melanoma cell lines
- (2009) Carmen S. Tellez et al. MELANOMA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started